BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 37651190)

  • 1. Posttranslational ISGylation of NLRP3 by HERC enzymes facilitates inflammasome activation in models of inflammation.
    Qin Y; Meng X; Wang M; Liang W; Xu R; Chen J; Song H; Fu Y; Li J; Gao C; Jia M; Zhao C; Zhao W
    J Clin Invest; 2023 Oct; 133(20):. PubMed ID: 37651190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ISGylation by HERCs facilitates STING activation.
    Qin Y; Wang M; Meng X; Wang M; Jiang H; Gao Y; Li J; Zhao C; Han C; Zhao W; Zheng X
    Cell Rep; 2024 May; 43(5):114135. PubMed ID: 38652662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM28 SUMOylates and stabilizes NLRP3 to facilitate inflammasome activation.
    Qin Y; Li Q; Liang W; Yan R; Tong L; Jia M; Zhao C; Zhao W
    Nat Commun; 2021 Aug; 12(1):4794. PubMed ID: 34373456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttranslational modifications of NLRP3 and their regulatory roles in inflammasome activation.
    Qin Y; Zhao W
    Eur J Immunol; 2023 Oct; 53(10):e2350382. PubMed ID: 37382218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARIH2 Ubiquitinates NLRP3 and Negatively Regulates NLRP3 Inflammasome Activation in Macrophages.
    Kawashima A; Karasawa T; Tago K; Kimura H; Kamata R; Usui-Kawanishi F; Watanabe S; Ohta S; Funakoshi-Tago M; Yanagisawa K; Kasahara T; Suzuki K; Takahashi M
    J Immunol; 2017 Nov; 199(10):3614-3622. PubMed ID: 29021376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome.
    Shim DW; Lee KH
    Front Immunol; 2018; 9():1054. PubMed ID: 29868015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The E3 Ubiquitin Ligase TRIM65 Negatively Regulates Inflammasome Activation Through Promoting Ubiquitination of NLRP3.
    Tang T; Li P; Zhou X; Wang R; Fan X; Yang M; Qi K
    Front Immunol; 2021; 12():741839. PubMed ID: 34512673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation.
    Pan P; Shen M; Yu Z; Ge W; Chen K; Tian M; Xiao F; Wang Z; Wang J; Jia Y; Wang W; Wan P; Zhang J; Chen W; Lei Z; Chen X; Luo Z; Zhang Q; Xu M; Li G; Li Y; Wu J
    Nat Commun; 2021 Aug; 12(1):4664. PubMed ID: 34341353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitination of NLRP3 by gp78/Insig-1 restrains NLRP3 inflammasome activation.
    Xu T; Yu W; Fang H; Wang Z; Chi Z; Guo X; Jiang D; Zhang K; Chen S; Li M; Guo Y; Zhang J; Yang D; Yu Q; Wang D; Zhang X
    Cell Death Differ; 2022 Aug; 29(8):1582-1595. PubMed ID: 35110683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The leucine-rich repeat (LRR) domain of NLRP3 is required for NLRP3 inflammasome activation in macrophages.
    Duan Y; Wang J; Cai J; Kelley N; He Y
    J Biol Chem; 2022 Dec; 298(12):102717. PubMed ID: 36403854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia.
    Tang J; Tu S; Lin G; Guo H; Yan C; Liu Q; Huang L; Tang N; Xiao Y; Pope RM; Rajaram MVS; Amer AO; Ahmer BM; Gunn JS; Wozniak DJ; Tao L; Coppola V; Zhang L; Langdon WY; Torrelles JB; Lipkowitz S; Zhang J
    J Exp Med; 2020 Apr; 217(4):. PubMed ID: 31999304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
    Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
    Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein.
    Yalcinkaya M; Liu W; Islam MN; Kotini AG; Gusarova GA; Fidler TP; Papapetrou EP; Bhattacharya J; Wang N; Tall AR
    Sci Rep; 2021 Dec; 11(1):24432. PubMed ID: 34952919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peli1 facilitates NLRP3 inflammasome activation by mediating ASC ubiquitination.
    Zhang L; Ko CJ; Li Y; Jie Z; Zhu L; Zhou X; Xie X; Gao T; Liu T; Cheng X; Sun SC
    Cell Rep; 2021 Oct; 37(4):109904. PubMed ID: 34706239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM50 promotes NLRP3 inflammasome activation by directly inducing NLRP3 oligomerization.
    Lin Y; Lv X; Sun C; Sun Y; Yang M; Ma D; Jing W; Zhao Y; Cheng Y; Xuan H; Han L
    EMBO Rep; 2022 Nov; 23(11):e54569. PubMed ID: 36178239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cullin1 binds and promotes NLRP3 ubiquitination to repress systematic inflammasome activation.
    Wan P; Zhang Q; Liu W; Jia Y; Ai S; Wang T; Wang W; Pan P; Yang G; Xiang Q; Huang S; Yang Q; Zhang W; Liu F; Tan Q; Zhang W; Wu K; Liu Y; Wu J
    FASEB J; 2019 Apr; 33(4):5793-5807. PubMed ID: 30653357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma.
    McKee CM; Coll RC
    J Leukoc Biol; 2020 Sep; 108(3):937-952. PubMed ID: 32745339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's disease.
    Yan YQ; Zheng R; Liu Y; Ruan Y; Lin ZH; Xue NJ; Chen Y; Zhang BR; Pu JL
    Aging Cell; 2023 Jun; 22(6):e13834. PubMed ID: 37029500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3.
    Wang D; Zhang Y; Xu X; Wu J; Peng Y; Li J; Luo R; Huang L; Liu L; Yu S; Zhang N; Lu B; Zhao K
    Nat Commun; 2021 May; 12(1):2674. PubMed ID: 33976226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.
    Lécuyer D; Nardacci R; Tannous D; Gutierrez-Mateyron E; Deva Nathan A; Subra F; Di Primio C; Quaranta P; Petit V; Richetta C; Mostefa-Kara A; Del Nonno F; Falasca L; Marlin R; Maisonnasse P; Delahousse J; Pascaud J; Deprez E; Naigeon M; Chaput N; Paci A; Saada V; Ghez D; Mariette X; Costa M; Pistello M; Allouch A; Delelis O; Piacentini M; Le Grand R; Perfettini JL
    Front Immunol; 2023; 14():1270081. PubMed ID: 37920468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.